Tauopathy Biochemistry

Tauopathies are neurodegenerative disorders that are caused due to the accumulation of abnormal tau proteins in neurons and/or the glia. Here is the latest research on tauopathy biochemistry.

March 8, 2020

Tauopathy-Associated Tau Fragment Ending at Amino Acid 224 Is Generated by Calpain-2 Cleavage

Journal of Alzheimer's Disease : JAD
Claudia CicognolaKina Höglund
January 15, 2020
Preprint
Open Access

25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner

BioRxiv : the Preprint Server for Biology
Man Ying WongWenjie Luo
July 6, 2020

In vivo positron emission tomography imaging of mitochondrial abnormalities in a mouse model of tauopathy

Neurobiology of Aging
Anna M BarronMakoto Higuchi
January 15, 2020

Hypoxia induces HT-22 neuronal cell death via Orai1/CDK5 pathway-mediated Tau hyperphosphorylation

American Journal of Translational Research
Binbin FangMengmeng Ou
March 16, 2020
Preprint
Open Access

High-contrast in-vivo imaging of tau pathologies in Alzheimer's and non-Alzheimer's disease tauopathies

MedRxiv : the Preprint Server for Health Sciences
K. TagaiH. Shimada
June 9, 2020

Bisphenol-A exposure induced neurotoxicity and associated with synapse and cytoskeleton in Neuro-2a cells

Toxicology in Vitro : an International Journal Published in Association with BIBRA
Zhihong YinYaming Ge
January 26, 2020

Sephin1 Reduces Prion Infection in Prion-Infected Cells and Animal Model

Molecular Neurobiology
Simrika ThapaHermann M Schatzl
March 21, 2020
Open Access

Neurodegeneration-Associated Proteins in Human Olfactory Neurons Collected by Nasal Brushing

Frontiers in Neuroscience
Lorenzo BrozzettiGianluigi Zanusso
December 28, 2019

New activators of eIF2α Kinase Heme-Regulated Inhibitor (HRI) with improved biophysical properties

European Journal of Medicinal Chemistry
Qingwen ZhangBertal H Aktas
April 21, 2020

A Multifunctional Chemical Agent as an Attenuator of Amyloid Burden and Neuroinflammation in Alzheimer's Disease

ACS Chemical Neuroscience
Hong-Jun ChoLiviu M Mirica
February 20, 2020
Open Access

Novel Approach for Detecting the Neurological or Behavioral Impact of Physiological Episodes (PEs) in Military Aircraft Crews

Military Medicine
Mohamed B Abou-Donia, Mulugu V Brahmajothi
January 7, 2020
Preprint
Open Access

Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson's disease at Chr16q11.2 and on the MAPT H1 allele.

BioRxiv : the Preprint Server for Biology
Marc SoutarHelene Plun-Favreau
May 19, 2020

Cross-Interplay between Osmolytes and mTOR in Alzheimer's disease pathogenesis

Current Pharmaceutical Design
Zeba MueedNitesh Kumar Poddar

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/tauopathy-biochemistry/cf253c17-da4c-4ee5-912f-deed325b7c13